Drug Shortage Report for IMITREX
| Report ID | 224362 |
| Drug Identification Number | 02230418 |
| Brand name | IMITREX |
| Common or Proper name | Sumatriptan nasal spray |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | SUMATRIPTAN |
| Strength(s) | 5MG |
| Dosage form(s) | SPRAY |
| Route of administration | NASAL NASAL |
| Packaging size | 2s |
| ATC code | N02CC |
| ATC description | ANTIMIGRAINE PREPARATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-04-04 |
| Estimated end date | 2024-05-10 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-04-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2024-04-05 | French | Compare |
| v1 | 2024-04-05 | English | Compare |
Showing 1 to 2 of 2